With a robust R&D facility, Neopharma aims to introduce new products across various therapeutic sectors at regular intervals, based on market needs.

“To progress into a globally admired and technology driven ‘integrated healthcare enterprise’, which shall continually innovate and adapt to deliver the best in the healthcare world”.


Neopharma is one of the leading pharmaceutical manufacturing companies in the UAE and is dedicated to the benevolent and wise leader, Father of the Nation, His Highness Sheikh Zayed Bin Sultan Al Nahyan.

Neopharma commenced operations in 2003 and the first set of manufacturing facilities were planned on an investment outlay of US$25 million. The organization’s inspiration stems from the vision to locally manufacture world class pharmaceuticals at affordable prices.


Established in 

Year 2003 with investment outlay of US$25 million

Annual Tablets Production

Potential 1500 million

Global Reach

More than 40 plus countries

Annual Capsules Production

Potential 300 million

Future Forward

Executive Vice Chairman & MD’s Message

Dr. B.R. Shetty

Executive Vice Chairman & Managing Director

The ‘NMC success story’ has been a memorable one for those who were an integral part of this journey. Sparked by a vision and driven by determination and commitment, This group has transformed from a humble one-room clinic in 1975 to one of the biggest healthcare conglomerates in the region. The company is now also listed on the London Stock Exchange.



Neopharma is one of the leading pharmaceutical manufacturing companies in the UAE and is dedicated to the benevolent and wise leader, Father of the...


  • Ministry of Health approves Neopharma to launch its generic version of Levofloxacin and Losartan Potassium.
  • Neopharma launches ”Renalka” Urinary alkalinizer- A quick remedy for pH balance.
  • Neopharma organizes voluntary blood donation campaign in collaboration with the Abu Dhabi Blood Bank on 16th September 2012 in the Company premises.
  • Neopharma receives approval for the launch of generic version of Pantoprazole 40mg gastro resistant tablets.
  • Neopharma launches generic version of Gliclazide Modified Release Tablets.
  • Neopharma, Abu Dhabi's leading generic pharmaceutical manufacturing facility inaugurated its dedicated world class research and development centre in Musaffah on September 10th, 2012. The research centre has collaborated with the Arkansas University for the development of microfiber nanotechnology for glucose sensors and nanotechnology based microchips for neurodegenerative disorders.

  • Neopharma makes its foray into CIS Markets with product launches in Tajikistan.
  • Neopharma introduces generic version of anti-diarrheal drug Loperamide in UAE.
  • Neopharma begins marketing of its first injectable product.
  • Neopharma launches generic version of Ivy Leaf extract Syrup.
  • Neopharma receives approval for the launch of generic version of Gliclazide Modified Release Tablets.
  • Neopharma receives approval for the launch of Urinary Alkalinizer, Fluconazole tablets and low osmolarity formula of Oral Rehydration Salts.
  • Neopharma further expands operations in the African Market by starting the registration process in Ethiopia and Tanzania.
  • Registration of first set of products completed in Turkmenistan.
  • The UAE Genetic Diseases Association and Neopharma have joined hands for introducing Manal. The launch of Manal will form an integral part of the UAE GDA vision to prevent neural tube defects in the United Arab Emirates by Health Education, Public Awareness and Folic Acid Supplementation targeted for specific population.

  • Neopharma has received the Certificate of EHS approval from the Abu Dhabi Emirate, Environment, Health and Safety Management System.

  • Products are introduced into one of the biggest markets in the region Saudi Arabia.
  • Neopharma starts Kuwait operations.
  • Neopharma moves into horizontal integration mode. Ground breaking ceremony heralds the start of new manufacturing facilities.

  • Neopharma starts operations in the Sultanate of Oman.
  • Neopharma becomes the first pharmaceutical company in the region to obtain the integrated management system encompassing ISO 9001, ISO 14001 & OHSAS 18001.
  • Contract manufacturing for Lagap, Switzerland.
  • Neopharma enters the Qatar pharmaceutical market.
  • The first exports to East Africa commences with dispatch to Kenya.
  • Neopharma enters the Afghanistan markets.

Neopharma, the leading pharmaceutical manufacturing company from the UAE currently works with some of the global
and regional pharmaceutical giants.